Jane Wasman, Executive VP, General Counsel & Secretary at ACORDA THERAPEUTICS INC (ACOR), sold 7,500 shares at $26.82 ($199K) on 2010-12-01, disclosed to the SEC on 2010-12-03.
Scheduled sale ($199k) by Executive VP, General Counsel & Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.38 | 4,900 | $129K | 65.0% |
| 2 | $26.82 | 2,600 | $70K | 35.0% |
| Total | $26.53 avg | 7,500 | $199K | 100% |
| Filing → |
| ACOR | SELL | 2018-12-06 | $126K | — | Filing → |
| ACOR | SELL | 2018-01-23 | $1.9M | — | Filing → |
| ACOR | SELL | 2017-12-05 | $187K | — | Filing → |